Non-secretory adenomas of the pituitary treated by trans-ethmoidal sellotomy
Summary A consecutive series of 35 clinically non-secretory pituitary adenomas treated surgically by the transethmoidal approach is presented. Mean age at presentation was 60 years, with a male-to-female ratio of 2 : 1. These tumours present later than hormone secreting tumours: 90% were over 2 cm in diameter at operation. Seventy-one per cent of patients had impaired vision and 89% had hypopituitarism. Surgical treatment relieved or significantly improved visual fields in 79% of patients with impaired vision. Ninety-one per cent required permanent hormone replacement. Mean follow-up was for 4.4 years. Five tumours recurred, causing recurrent visual symptoms. No tumours recurred in those patients treated with postoperative radiotherapy, but follow-up in this group was only for a mean of 2.7 years. Most pituitary tumours present clinically when still small with symptoms and signs of hormone secretion by the tumour. Clinically non-secretory tumours usually present much later, either with signs of an enlarging space-occupying lesion, or with hypopituitarism as the tumour expands and destroys the normal functioning pituitary tissue. The definition of non-secretory adenomas causes difficulty in two areas. Immunocytochemical assessment of the tumour tissue does not always correlate with the biochemical status of the patient: for example the tumour may show positive staining for one or more pituitary hormones (or demonstrate hormone secretion when cultured) in a patient with no clinical or biochemical evidence of hormonal hypersecretion. In these cases it is assumed that the hormoneis) is not being secreted in vivo in biochemically significant amounts'r'.
A second problem with the clinical definition of nonsecretory adenomas is that large tumours compress the pituitary stalk, thereby obstructing the normal inhibitory dopaminergic influence of the hypothalamus on the lactotroph. Such stalk compression is commonly associated with mild hyperprolactinaemia (usually < 1000-1500 mUll) even though the pituitary tumour itself is non-secretory.
For the purposes of this paper the term 'clinically non-secretory tumour' includes tumours that are clinically and biochemically non-secretory, regardless ofthe results of immunocytochemical analysis of the resected tumour; it also includes cases where the serum prolactin is raised simply due to stalk compression. The relationship between the clinical and biochemical findings of these tumours and their immunocytochemical characteristics will be described elsewhere.
Patient population
There were 35 patients, with a mean age of 60 years (range 29-77); there were 24 males and 11 females.
Presenting complaint
The initial complaints that brought the patient to medical attention are shown in Table 1 . Most patients had symptoms and signs of either hypopituitarism or visual disturbance. Five patients presented initially with the clinical picture of hypothyroidism, and investigations subsequently showed a pituitary origin. Three patients presented with extreme prostration due to hypoadrenalism; one other had an acute Addisonian crisis associated with the sudden onset of headache, vomiting and diplopia, ie pituitary apoplexy (infarction of the gland was confirmed on histology). One patient was found incidentally to have an enlarged pituitary fossa which was seen on a radiograph taken for cervical spondylosis. The patient had no signs of a pituitary tumour and was endocrinelogically normal.
Three patients were secondary referrals, having previously had a trans-frontal craniotomy for excision of a non-secretory adenoma. After 7, 13 and 20 years respectively they were referred for trans-sphenoidal surgery because of recurrence: in each case the presenting symptom of recurrence was visual impairment.
Clinical and biochemical findings
The clinical findings on examination are shown in Table 2 . Eighty-three per cent had clinical evidence
Operative findings
All patients were operated on by the same surgeon (SHR) via a trans-ethmoidal trans-sphenoidal approach. The findings are listed in Table 3 . It can be seen that many of the tumours were large; 83% had a suprasellar extension, and many tumours had eroded through the floor of the fossa into the sphenoid sinus. It is this last feature that makes the transsphenoidal approach essential, as these tumours are not accessible via trans-frontal craniotomy. Removal of the suprasellar extension via the trans-sphenoidal
Radiological findings
Thirty-four of the 35 patients had an enlarged and/or eroded pituitary fossa on plain radiography of the skull. Twenty-nine patients had computerized tomography (C'T), but high resolution CT was only available for the latter part of the series. Twenty-six out of the 29 CT scans showed a suprasellar extension to the tumour; eight had compression of the cavernous sinusres); 16 showed erosion of the sellar floor; and 13 showed tumour occupying part or all of the sphenoid sinus. Six patients were investigated before CT became available: five of these had air-encephalography to assess the degree of suprasellar extension, which was present in three and absent in two.
of hypopituitarism, such as weakness, tiredness, sexual deficiency, soft pale skin, thin and reduced body hair, etc. Seventy-one per cent had impairment of vision confirmed on visual perimetry testing; those with severe restriction of fields had impaired acuity also. All the other patients had normal perimetry. One patient developed her initial visual symptoms during pregnancy.
All patients (except one who required urgent surgery) underwent full endocrinological assessment prior to surgery using standard tests of hypothalamicpituitary and target gland function as outlined previously'', Thirty-one patients (89%) had hypopituitarism of varying degrees, and two patients had completely normal profiles. Two patients had normal pituitary function apart from raised prolactin levels. Three patients had hyperprolactinaemia together with hypopituitarism. All 5 of the patients with hyperprolactinaemia had large tumours (> 1 cm diameter) but only marginal elevation of prolactin levels (< 1000 mUll), commensurate with stalk compression hyperprolactinaemia. approach is not a problem provided the tumour has not extended behind the dorsum sellae or invaded the cerebral substance.
In most cases (23 out of 35) it was necessary to remove the whole pituitary gland to achieve complete tumour removal. In seven cases a rim of normal gland was preserved, but five of these were later found to need permanent full hormone supplementation and of the other two one needed thyroxine and testosterone and the other (a post-menopausal female) needed thyroxine. In five cases, it was only possible to perform decompression with incomplete tumour removal.
Cerebrospinal fluid (CSF) drainage at the time of the operation was controlled at the end of the procedure by inserting a muscle graft into the pituitary fossa and suturing the dura. Three patients developed a CSF leak postoperatively. They all ceased spontaneously after a few days. One of these three developed meningitis which resolved rapidly with antibiotics.
Many tumours extended laterally to compress the cavernous sinus (one actually eroding into it) and the ethmo-sphenoidal approach gave excellent access to these lateral extensions.
In nine cases the tumour was macroscopically invading dura and in three the adjacent bone was invaded as well. In all these cases the completeness of tumour removal was doubtful and was an indication for postoperative radiotherapy (see below).
Histopathology
Histological staining of the adenomas showed that most were of the chromophobe type, but seven were acidophilic and four were chromophobe with a variable number of eosinophilic cells also within the adenoma. Clearly some tumours which are clinically and biochemically non-secretory have eosinophilic cytoplasmic granules. Tumours from patients with mild hyperprolactinaemia, assumed to be due to stalk compression, did not show positive immunocytochemical staining for prolactin. All these tumours are currently being studied in greater detail and will be discussed in another paper which examines the immunocytochemical aspects of clinically nonsecretory adenomas.
Results

Surgical morbidity
There were no peri-operative deaths. Complications were few. The most serious was unilateral blindness in one patient. She had had a trans-frontal craniotomy for a large tumour and postoperative radiotherapy 7 years before. Removal of the tumour was difficult because of suprasellar adhesions from her previous surgery. There was later some partial recovery of her sight.
One patient had unilateral epiphora lasting 6 months before it spontaneously resolved; this was due to disturbance of the lacrimal apparatus which has to be mobilized during the surgical approach.
Occasionally there was some minor infection or haematoma formation in the leg wound, the donor site for the muscle graft.
Endocrine results
The results are shown in Table 4 . Thirty-two out of the 35 patients required hormone supplements longterm. Of the 31 patients who had hypopituitarism preoperatively, almost all remained deficient after Table 4 . centre. The other three patients have had radiotherapy and remain recurrence-free after a mean of 2 years.
Visual loss
Twenty-four patients had reduced visual fields when measured objectively by perimetry pre-operatively. Out ofthese, eight returned to normal when measured after surgery, 11 improved significantly, four patients showed no improvement, and one was worse.
Recurrence rate
For the 32 patients who had primary trans-sphenoidal surgery, follow-up was from 1 to 13 years (mean 4.4 years). Twenty-seven are recurrence free and five have developed recurrence, after 2, 3, 3, 5 and 6 years respectively. None of these five patients had had postoperative radiotherapy; each recurrence was associated with deterioration of vision.
Of the five patients with recurrence, one refused further treatment or follow-up. One patient changed address and had radiotherapy and two revision operations via the trans-frontal route at another operation; just two became normal with no supplementation afterwards (although one of these was only thyroid-deficient before). Six patients required longterm desmopressin treatment, but one of these was able to be weaned off after 6 months. Two patients developed late hyperprolactinaemia and were treated with bromocriptine.
Out of the four patients with normal pituitary function preoperatively (including those with raised prolactin from stalk compression), three had hypopituitarism afterwards. In two of these three a small rim of normal gland had been preserved. Curiously, the one patient who had normal endocrine function both before and after surgery had a large tumour that was macroscopically invading the bone of the sphenoid over a wide area; no apparently normal gland tissue had been preserved at surgery.
Postoperative radiotherapy
Ten patients were electively treated with a radical course of postoperative radiotherapy after primary trans-sphenoidal surgery. The indications were either doubt about the completeness of excision and/or an aggressive histological picture. None of these 10 patients has any evidence of recurrence so far, after 6 months' to 6 years' follow-up (mean 2.7 years).
The remaining 22 patients who had primary trans-sphenoidal surgery were not given elective postoperative radiotherapy. Seventeen of these remain recurrence-free after 1-13 years (mean 4.7 years). Five patients developed a recurrence, after 2-6 years (mean 3.8 years).
We have used elective postoperative radiotherapy more in recent years than formerly; accordingly the length offollow-up for the radiotherapy patients has not been long, but despite this the results tend to support the use of radiotherapy where there is any doubt about the completeness of excision or the aggressiveness of the histological picture.
Discussion
There are very few reports of the results of transsphenoidal surgery for large series of clinically non-secretory adenomas. In 1986 Ebersold et al. 4 reported on 100 cases treated at the Mayo clinic. Their findings were similar to ours: there was a male preponderance (sex ratio 3: 1); mean age was 57; presenting symptoms were visual in 72% and of hypopituitarism in 61%. After a mean 6 years' followup, 16 tumours recurred (only six symptomatically), the recurrences being almost equal between a group that had had postoperative radiotherapy and a group that had not (although radiotherapy was given to those patients thought to have a higher chance of recurrence). Out of 61 who had hypopituitarism preoperatively, 10 returned to normal; five had permanent diabetes insipidus.
In 1987 Bevan et al. 5 reported on a series of 58 patients. There was only a slight male preponderance (1.2 : 1);mean age was 54 years; presenting symptoms were visual in 57% and of hypopituitarism in less than 64%. Only two tumour recurrences were detected (neither having had radiotherapy) although mean follow-up was short.
Arafah" reported on endocrine findings in a series of26 patients with clinically non-secretory adenomas treated by trans-sphenoidal surgery. Eighty-one per ·cent were deficient in thyroid function preoperatively, 57% of these becoming deficient afterwards. We found that only 14% of the whole group became sufficient in thyroid function and 20% became sufficient in adrenal function. This may reflect more radical surgery in our series; alternatively it may reflect the possibility that in our series the patients presented at a later stage, as evidenced by the fact that we had a higher incidence of visual symptoms and of hypopituitarism at presentation.
Compared with functioning pituitary tumours, clinically non-secretory tumours present late; there was an 89% incidence of hypopituitarism and a 71% incidence of visual impairment at presentation. Moreover 91% of these tumours were found to be 2 em or more in diameter at operation compared with only 10% of prolactinomas and 45% of growth hormone secreting tumours in the authors' series of 280 pituitary tumours of all types operated on by this approach.
At operation it was found that the wide and relatively short approach offered by the transsphenoidal route was very satisfactory, particularly for dealing with the lateral and inferior extensions of these large tumours. The access was also satisfactory for removing a suprasellar extension, providing there were no suprasellar adhesions from previous transfrontal surgery.
In view of the unknown histology of clinically nonsecretory tumours, we advocate early exploration by this route, in order to establish the diagnosis and to effect removal.
As none of the patients in this series who had elective postoperative radiotherapy have shown any sign of recurrence to date, we recommend this treatment in cases where the tumour shows invasive features or where total removal is not possible. The use of salvage radiotherapy for recurrence requires a BMJ 1985; 291:1547-50 Forthcoming events 
